- Vishay Intertechnology 2Q Adj EPS 19c >VSH
- Vishay Intertechnology 2Q EPS 19c >VSH
- Criteo Q2 2026 net income drops 40% to USD 12 million; revenue falls 11% to USD 428 million
- LEIDOS <LDOS.N>: STIFEL CUTS TARGET PRICE TO $142 FROM $193
- Lifecore Biomedical Q2 FY26 net loss widens to $6.2 million; revenue falls 6.2% to $34.2 million
- ZEBRA TECHNOLOGIES <ZBRA.O>: TRUIST SECURITIES RAISES TARGET PRICE TO $355 FROM $296
- New York Times Q2 FY26 diluted EPS rises to $0.57; revenue increases 11.2% to $762.5 million
- WAYFAIR INC. <W.N>: TRUIST SECURITIES RAISES TARGET PRICE TO $135 FROM $99
- Regal Rexnord Narrows 2026 View To Adj EPS $10.35-Adj EPS $10.85 >RRX
- Hercules Metals plans C$4.5 million private placement at C$0.62/share to incoming management team
- Regal Rexnord Narrows 2026 View To EPS $5.42-EPS $5.92 >RRX
- Terawulf Q2 FY26 net loss widens to $940.83 million; revenue falls 6% to $44.77 million
- VISA INC. <V.N>: TRUIST SECURITIES RAISES TARGET PRICE TO $406 FROM $394
- BOOKING HOLDINGS INC. <BKNG.O>: WEDBUSH RAISES TARGET PRICE TO $247 FROM $211
- LATTICE SEMICONDUCTOR CORPORATION <LSCC.O>: STIFEL RAISES TARGET PRICE TO $165 FROM $145
- VERTEX PHARMACEUTICALS INCORPORATED <VRTX.O>: TRUIST SECURITIES RAISES TARGET PRICE TO $565 FROM $560
- West Point Gold drills 30.4 m at 2.31 g/t gold at Tyro Main Zone, Arizona Gold Chain project
- TAT Technologies Q2 FY26 net income more than doubled to $8.07 million; revenue rises 22.8% to $52.9 million
- Val-d'Or Mining says Perestroika drill hole PE-26-027 hits 3.08 g/t gold over 84 m
- INTAPP, INC. <INTA.O>: STIFEL RAISES TARGET PRICE TO $45 FROM $35
- SBA COMMUNICATIONS CORP <SBAC.O>: TRUIST SECURITIES CUTS TARGET PRICE TO $238 FROM $248
- Pirate Gold maps 3 km of advanced argillic alteration at Clipper Brook target in Newfoundland
- Regal Rexnord 2Q Adj EPS $2.99 >RRX
- Pyxus International 1Q Rev $437.8M >PYYX
- Plastec Technologies deregisters ordinary shares under Exchange Act Section 12(g)
- QUALYS, INC. <QLYS.O>: TRUIST SECURITIES RAISES TARGET PRICE TO $185 FROM $160
- Nacon says Bigben debt revamp hinges on court-approved reorganization plan, warns of heavy shareholder dilution
- Amex Gold Mining completes portal blasting for Perron bulk sample program
- Kobrea forms exploration alliance with BHP Metals Exploration on Argentina copper projects
- Spire FY26 Q3 net loss widens to $42.6 million; revenue rises to $420.2 million
- HINGE HEALTH, INC. <HNGE.N>: STIFEL RAISES TARGET PRICE TO $96 FROM $90
- Excellon Resources produces first concentrate at Mallay mine in Peru
- Seres Therapeutics returns to Q2 FY26 net income of 4.58 million; revenue rises to 736,000
- Coyote Copper Mines expands Copper Springs land package by 2,000 acres after soil survey results
- Banca Popolare di Puglia e Basilicata shareholders approve charter changes at meeting
- Astec 2Q FY26 net income drops 37.1% to $10.5 million; net sales rise 23.6% to $408.1 million
- Kraft Heinz declares quarterly dividend of $0.40 a share
- Kaltura Q2 FY26 net loss narrows to $5.5 million; revenue rises 5% to $46.9 million
- Aurora Cannabis FY27 Q1 net loss narrows to C$4.03 million; revenue falls 9% to C$67.6 million
- ONSEMI <ON.O>: TRUIST SECURITIES CUTS TARGET PRICE TO $91 FROM $101
- HENRY SCHEIN, INC. <HSIC.O>: STIFEL RAISES TARGET PRICE TO $95 FROM $84
- The spot premium of Middle Eastern benchmark crude oil has declined, as the expected reopening of the Hormuz Strait signals an easing of supply constraints.
- Uber shares slipped over 3% in premarket trading; total gross bookings for the second quarter reached $58.02 billion, surpassing the market expectation of $57.17 billion; the company expects total gross bookings for the third quarter to be between $58.25 billion and $60.25 billion, while the market anticipated $59.32 billion.
- Kraft Heinz Q2 FY26 net loss narrows to $5.46 billion; net sales drop 1.4% to $6.26 billion
- GULFPORT ENERGY CORPORATION <GPOR.N>: TRUIST SECURITIES CUTS TARGET PRICE TO $186 FROM $190
- Pyxus Q1 FY27 net loss narrows 53.8% to $7.3 million; sales and other operating revenues fall 14% to $437.8 million
- GARTNER <IT.N>: TRUIST SECURITIES RAISES TARGET PRICE TO $205 FROM $170
- DIAMONDBACK ENERGY, INC. <FANG.O>: TRUIST SECURITIES RAISES TARGET PRICE TO $224 FROM $220
- Cushman & Wakefield Q2 FY26 net income falls 8% to $52.7 million; revenue rises 11% to $2.8 billion
- Advantage Solutions Q2 FY26 net loss more than doubles to $62.7 million; revenue rises 1.8% to $889.5 million
- CUMMINS <CMI.N>: TRUIST SECURITIES CUTS TARGET PRICE TO $894 FROM $901
- WAYFAIR <W.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $120 FROM $75
- ENTEGRIS, INC. <ENTG.O>: DEUTSCHE BANK CUTS TARGET PRICE TO $152 FROM $155
- COMPASS <COMP.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $15 FROM $13
- WATERS <WAT.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $400 FROM $380
- PEDIATRIX MEDICAL GROUP <MD.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $25 FROM $19
- DAVITA, INC. <DVA.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $265 FROM $220
- TPG INC <TPG.O>: DEUTSCHE BANK RAISES TARGET PRICE TO $62 FROM $53
- BWX TECHNOLOGIES <BWXT.N>: DEUTSCHE BANK CUTS TARGET PRICE TO $253 FROM $255
- GARTNER <IT.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $210 FROM $180
- GRAPHIC PACKAGING <GPK.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $11.9 FROM $11.1
- TREX <TREX.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $53 FROM $51
- HIGHWOODS PROPERTIES, INC <HIW.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $33 FROM $28
- HIGHWOODS PROPERTIES, INC <HIW.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $33 FROM $28
- RED ROCK RESORTS <RRR.O>: DEUTSCHE BANK RAISES TARGET PRICE TO $73 FROM $72
- SYSCO <SYY.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $89 FROM $86
- WYNN RESORTS <WYNN.O>: DEUTSCHE BANK RAISES TARGET PRICE TO $139 FROM $137
- CATERPILLAR INC <CAT.N>: TRUIST SECURITIES RAISES TARGET PRICE TO $1225 FROM $1218
- Hennessy Capital Investment Corp. VII announces shareholder meeting to vote on ONE Nuclear deal
- Kymera Q2 FY26 net loss narrows to $61.21 million; revenue more than doubles to $65 million
- Seres Therapeutics 2Q Research and Development Expenses $9.1M >MCRB
- Valvoline Adjusts 2026 View To Adj EPS $1.70-Adj EPS $1.75 >VVV
- ARISTA NETWORKS INC : TRUIST SECURITIES RAISES TARGET PRICE TO $234 FROM $175
- Factorial Energy to attend Oppenheimer technology investor conference
- ADVANCED MICRO DEVICES : TRUIST SECURITIES RAISES TARGET PRICE TO $594 FROM $478
- InMode Q2 FY26 GAAP net income drops 36.2% to $17.1 million; revenue flat at $95.6 million
- Galaxy Digital Q2 FY26 net loss narrows to $85 million; total assets rise 9% QoQ to $10.84 billion
- ADAPTHEALTH CORP. : TRUIST SECURITIES CUTS TARGET PRICE TO $9 FROM $14
- BRIEF-Kyndryl Holdings Q1 EPS USD -0.25
- Entrada Therapeutics 2Q Rev $898,000 >TRDA
- Valvoline Adjusts 2026 View To Rev $2.05B-$2.1B >VVV
- Entrada Therapeutics 2Q Loss/Shr $1.01 >TRDA
- Valvoline Raises 2026 System-wide SSS Growth to 7.5%-8% >VVV
- TRANSDIGM GROUP INCORPORATED <TDG.N>: STIFEL CUTS TO HOLD FROM BUY; CUTS TARGET PRICE TO $1405 FROM $1525
- Eton Pharmaceuticals plans ASN-001 NDA submission in 2H 2027 after infantile hemangioma Phase II/III data
- SharkNinja Q2 FY26 net income drops 7% to $129.8 million; net sales rise 22.2% to $1.77 billion
- CDW Q2 FY26 net income rises 1.2% to $274.4 million; net sales increase 10% to $6.57 billion
- Acacia Research Q2 FY26 adjusted diluted EPS rises to $0.13; revenue more than doubles to $114.6 million year over year
- Royalty Pharma Raises 2026 Portfolio Receipts View to $3.4B-$3.5B >RPRX
- Charles River Labs Sees FY26 Adj EPS $11.15-Adj EPS $11.45 >CRL
- Lifecore Biomedical 2Q Adjusted EBITDA $8.6M >LFCR
- Correct: Charles River Labs Sees FY26 EPS $3.05-EPS $3.35 >CRL
- Kyndryl Reaffirms FY27 Outlook for Revenue, Earnings and Free Cash Flow >KD
- Kyndryl 1Q Rev $3.6B >KD
- Kyndryl 1Q Loss/Shr 25c >KD
- Lifecore Biomedical 2Q Rev $34.2M >LFCR
- Charles River Labs Sees 3Q EPS $3.05-EPS $3.35 >CRL
- VersaBank Says SEC's Declaration is Final Requisite Step Prior to Shareholder Meeting on Sept 16
- J&J Snack Foods 3Q Adj EPS $1.96 >JJSF
- Shopify 2Q Rev $3.58B >SHOP
